Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01103934 · ClinicalTrials.gov registry record · Phase 4
Vitamin D Plus Fluticasone Propionate
A Phase 4 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT01103934 is a Phase 4 study that has completed, run by University of Chicago. The registered enrollment target is 35 participants.
The verdict
NCT01103934, a Phase 4 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The objectives of this study would be to see if the addition of vitamin D to fluticasone propionate provides greater symptomatic relief in patients with seasonal allergic rhinitis compared to fluticasone propionate treatment alone.
Interventions
- DRUG Placebo
- DRUG Vitamin D3
- DRUG Fluticasone Propionate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01103934
The ClinicalTrials.gov registry entry for NCT01103934 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01103934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01103934 about?
NCT01103934 is a clinical study titled "Vitamin D Plus Fluticasone Propionate". The objectives of this study would be to see if the addition of vitamin D to fluticasone propionate provides greater symptomatic relief in patients with seasonal allergic rhinitis compared to fluticasone propionate treatment alone.
What is the current status of trial NCT01103934?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2010-06. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01103934?
The interventions under investigation include: Placebo (DRUG), Vitamin D3 (DRUG), Fluticasone Propionate (DRUG).
Who is sponsoring clinical trial NCT01103934?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.